These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 20941619)

  • 1. Transforming growth factor-beta: recent advances on its role in immune tolerance.
    Mantel PY; Schmidt-Weber CB
    Methods Mol Biol; 2011; 677():303-38. PubMed ID: 20941619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta as a promising option in the treatment of multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
    Zhang L; Yi H; Xia XP; Zhao Y
    Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta signalling and immunity in prostate tumourigenesis.
    Diener KR; Need EF; Buchanan G; Hayball JD
    Expert Opin Ther Targets; 2010 Feb; 14(2):179-92. PubMed ID: 20055717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of transforming growth factor beta (TGF-beta1) in human epithelial alveolar cells: a pro-inflammatory mediator independent pathway.
    Kwong KY; Literat A; Zhu NL; Huang HH; Li C; Jones CA; Minoo P
    Life Sci; 2004 Apr; 74(24):2941-57. PubMed ID: 15051419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).
    Chegini N
    Eur J Surg Suppl; 1997; (577):17-23. PubMed ID: 9076448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
    Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S
    Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation.
    Schmidt-Weber CB; Blaser K
    Curr Opin Immunol; 2004 Dec; 16(6):709-16. PubMed ID: 15511662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta and the immune response: implications for anticancer therapy.
    Wrzesinski SH; Wan YY; Flavell RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5262-70. PubMed ID: 17875754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of transforming growth factor-beta1 in prostate cancer.
    Wikström P; Damber J; Bergh A
    Microsc Res Tech; 2001 Feb; 52(4):411-9. PubMed ID: 11170300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
    Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
    Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta signal transduction.
    Dennler S; Goumans MJ; ten Dijke P
    J Leukoc Biol; 2002 May; 71(5):731-40. PubMed ID: 11994497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.
    Mantel PY; Kuipers H; Boyman O; Rhyner C; Ouaked N; Rückert B; Karagiannidis C; Lambrecht BN; Hendriks RW; Crameri R; Akdis CA; Blaser K; Schmidt-Weber CB
    PLoS Biol; 2007 Dec; 5(12):e329. PubMed ID: 18162042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
    Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
    J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing.
    Schiller M; Javelaud D; Mauviel A
    J Dermatol Sci; 2004 Aug; 35(2):83-92. PubMed ID: 15265520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.